Study Design: Retrospective case series.
Objective: To characterize failure rates of cervical cages based on manufacturer and design characteristics using the nationwide database of reported malfunctions.
Background: The Food and Drug Administration (FDA) aims to ensure the safety and efficacy of cervical interbody implants postimplantation; however, intraoperative malfunctions may be overlooked.
Study Design: A retrospective case series.
Objective: This study aims to assess the rates of lumbar interbody cage failures based on their material and manufacturer.
Summary Of Background Data: Perioperative lumbar interbody cage malfunctions are underreported events in the spine literature and may result in complications.
The increasing adoption of minimally invasive techniques for spine surgery in recent years has led to significant advancements in instrumentation for lumbar interbody fusion. Percutaneous pedicle screw fixation is now a mature technology, but the role of expandable cages is still evolving. The capability to deliver a multiexpandable interbody cage with a large footprint through a narrow surgical cannula represents a significant advancement in spinal surgery technology.
View Article and Find Full Text PDFStudy Design: Nondestructive flexibility tests were performed in vitro, comparing multiple conditions of fixation in a single group of specimens.
Objective: To compare the biomechanical behavior of the lumbar spine in the intact condition, after implanting a novel motion stabilizer, and after implanting a rigid fixator.
Summary Of Background Data: Two specific scenarios that may benefit from dynamic lumbar stabilization are single-level moderate instability, where the stabilizing tissues are relatively incompetent, and juxta-level to fusion, where the last instrumented level requires intermediate stiffness ("topping off") to prevent transfer of high stresses from the stiffer fusion construct to the intact adjacent levels.
Study Design: Multicenter, prospective single-arm study in patients diagnosed with neurogenic intermittent claudication because of lumbar spinal stenosis.
Objective: To collect data from 2 different primary patient populations, new participants meeting entry criteria [Continued Access Program (CAP)], or subjects who had been randomly assigned to nonsurgical management in the pivotal Investigational Device Exemption study and failed to respond upon study completion [Crossover Study (COS)].
Summary Of Background Data: The X-STOP interspinous spacer is a minimally invasive treatment option for neurogenic intermittent claudication shown to improve pain, physical functioning, and/or overall quality of life.